The $75 figure is a calculated average, not an official published consensus. It reflects 13 current targets compiled by S&P Global, which span from $42.50 to $108—an unusually wide gap that signals genuine disagreement about the business. The arithmetic mean is about $74.68, rounded to $75. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
On the bullish side, Roth MKM maintained a Buy and a $108 target in mid-October 2026, arguing the launch schedule still supports commercial service in late 2026 and 2027 sales approaching $1 billion. Deutsche Bank upgraded the stock to Buy with a $93 target on October 12, contending that the licensed spectrum alone covers most of the company's enterprise value. Berenberg Bank initiated coverage with a Buy and $92 target in September.
The cautious camp is equally vocal. Piper Sandler's Alexander Potter downgraded the stock to Neutral and cut his target to $54 from $98 on October 13, citing "lower conviction in the pace of satellite launches in 2026-2027" and rising SpaceX competition. Barclays carries a Sell rating with a $60 target, while Scotiabank's target is a modest $56 even after an upgrade to Buy. In other words, the average hides a battle between analysts who see a spectrum-rich growth story and those who see execution and competitive risk.
With the stock near $39.79, the required move to $75 is approximately 88%. That is a very large move by any standard, roughly equivalent to recovering much of a decline that has left the shares down about 42% in 2026 and more than 70% below their 52-week high of $133.86. From what I see, this distance underscores just how much execution needs to improve for any meaningful re-rating.
Reaching $75 would likely require the market to re-rate the company as its commercial milestones land. Key signposts include the launch of BlueBird satellites 14 through 16, an FCC meeting on spectrum matters, and third-quarter capital expenditures within management's $350 million to $425 million guidance. Wall Street expects 2026 revenue around $167 million and 2027 revenue near $600 million—a path that, if met, could support a substantially higher valuation, but one that remains unproven.
The stock is trading near its 52-week low of $36.72, which now acts as the nearest support level. A breakdown below that would open uncharted downside. On the way to $75, the shares would first need to reclaim the $50 psychological level, then the 50-day moving average around $57, before confronting resistance near $60 and the 200-day moving average around $79. The wide gap between the current price and the 200-day average illustrates how deeply the uptrend has broken down. I’m watching this closely with the help of Tickeron’s AI Trend Prediction Engine for any early shifts in momentum.
Analyst price targets typically reflect a research horizon of about 12 months, though individual analysts apply different periods and some targets embed multi-year growth assumptions that extend well beyond 2027. Investors should watch the November 9, 2026 earnings report, the FCC's late-October meeting, BlueBird launch progress, any changes to analyst launch estimates, and signs of additional financing or dilution. Competitive moves by SpaceX remain the single most important external variable.
In my own process, Tickeron's AI Daily Buy/Sell Signals have become a useful part of monitoring names like this. The tool applies artificial intelligence to track thousands of stocks and ETFs in real time, producing Buy, Sell, or Hold signals based on technical behavior and changing conditions. For a volatile stock such as AST SpaceMobile (ASTS), it helps highlight potential turning points without requiring constant manual review.
The question of whether AST SpaceMobile (ASTS) can reach $75 ultimately hinges on execution. The $75 target—the mean of 13 analyst estimates ranging from $42.50 to $108—requires an approximately 88% advance from recent levels, a very large move that would demand both successful satellite launches and a significant re-rating of the stock. Bulls point to scarce spectrum assets and carrier partnerships; bears point to SpaceX, launch delays, and heavy cash burn. With such a wide analyst range and shares sitting near their lows, the next several months of launch and regulatory news will determine whether the target is a realistic destination or a distant aspiration.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ASTS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 09, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In 43 of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASTS as a result. In 70 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
ASTS moved below its 50-day moving average on October 07, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for ASTS entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
ASTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.298) is normal, around the industry mean (6.969). P/E Ratio (-18.507) is within average values for comparable stocks, (6.322). ASTS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.778). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. ASTS's P/S Ratio (147.059) is very high in comparison to the industry average of (11.937).
The Tickeron Profit vs. Risk Rating rating for this company is 79 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
The Tickeron Price Growth Rating for this company is 87 (best 1 - 100 worst), indicating slightly worse than average price growth. ASTS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a blank check company, which has formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization
Industry TelecommunicationsEquipment